The B2B leaders outperforming peers in ROI aren't collecting more data; they're building smarter, connected ecosystems where ...
AstraZeneca’s IMFINZI® (durvalumab) in combination with standard-of-care FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, and docetaxel) has been approved in the US for the treatment of adult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback